mitochondrial pyruvate carrier (MPC) inhibitor by Pelage in early trials
a potent but unapproved and potentially problematic topical anti-androgen
JAK inhibitor that reduces inflammation and immune attacks on hair follicles, leading to potential hair regrowth, especially in alopecia areata cases